The DESiGN trial (DEtection of Small for Gestational age Neonate), evaluating the effect of the Growth Assessment Protocol (GAP): study protocol for a randomised controlled trial

Autor: Vieira, MC, Relph, S, Copas, A, Healey, A, Coxon, K, Alagna, A, Briley, A, Johnson, M, Lawlor, DA, Lees, C, Marlow, N, McCowan, L, Page, L, Peebles, D, Shennan, A, Thilaganathan, B, Khalil, A, Sandall, J, Pasupathy, D, Brocklehurst, P, Tebbs, S, Doré, C, Seed, P, Delaney, L, Cresswell, J, Petty, S, Ajay, B, Wright, B, O'Donnell, H, Howard, M, Wayman, E, Galea, P, Dhanjal, M, Iaschi, E, Hodge, V, Samarage, H, Chita, S, Napolitano, R, Tsikimi, I, Ghalustians, F, Bakalis, S, Cicero, S, Peregrine, E, Smith, L, Janga, D, Hutt, R, Chandraharan, E

Publikováno v: Trials, Vol 20, Iss 1, Pp 1-14 (2019)
Trials
2019, ' The DESiGN trial (DEtection of Small for Gestational age Neonate), evaluating the effect of the Growth Assessment Protocol (GAP) : Study protocol for a randomised controlled trial ', Trials, vol. 20, no. 1, 154 . https://doi.org/10.1186/s13063-019-3242-6

Background Stillbirth rates in the United Kingdom (UK) are amongst the highest of all developed nations. The association between small-for-gestational-age (SGA) foetuses and stillbirth is well established, and observational studies suggest that impro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363d68fe32c43eb8dff3d7450bb146de
https://lirias.kuleuven.be/handle/20.500.12942/694190

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.